October 17, 2025

FDA Awards Nine CNPV Vouchers to Speed Reviews

Pilot aims to expedite access to high‑impact therapies by streamlining FDA review and strengthening sponsor–agency collaboration.

Conexiant

October 17, 2025

Your Guide to Referring to the Center for Heart Rhythm Disorders

The Center for Heart Rhythm Disorders at Miami Cardiac & Vascular Institute offers streamlined, expert evaluation and management of arrhythmias.

Baptist Health South Florida

October 17, 2025

Stem Cell Study Uncovers Glial Cells That Accelerate Progressive MS 

Using a “disease-in-a-dish” model, researchers uncover glial cells that fuel chronic inflammation and neurodegeneration in progressive multiple sclerosis

The Analytical Scientist

October 17, 2025

Where Renal Cancer Strikes Hardest – and Why the Numbers Are Climbing Fast

Global analysis reveals sharp rises in incidence, survival gaps across regions, and key genetic risk factors shaping diagnostics

The Pathologist

October 17, 2025

Decentralized CAR-T: From Vision to Viability

What will it take to make decentralized CAR-T manufacturing work in the real world? Three experts discuss in this roundtable.

The Medicine Maker

October 16, 2025

HHS Memo: Fringe Finds a Footing

From wheat fields to Washington: a decades-old fear about skies and 'sprays' rises again, colliding with science, social media, and the machinery of federal policymaking.

KFF Health News

October 16, 2025

Pickleball’s Eye-Opening Problem

A sharp rise in pickleball-related eye injuries prompts researchers to call for standardized eye protection to prevent vision-threatening trauma.

Conexiant

October 16, 2025

Hidden Disparities in Med Schools Uncovered

Researchers found that US medical students with disabilities—especially women of color—face higher rates of discrimination.

Conexiant

October 16, 2025

New Criteria, New Numbers on Obesity

A Lancet Commission definition integrating BMI with anthropometric measures increased obesity prevalence by ~60% in a major US cohort, identifying previously unrecognized high-risk patients while introducing distinct clinical phenotypes.

Conexiant